3.0.0
1844
2025-12-05T08:07:38Z
2025-12-05T08:07:38Z
Senate
S
S
2023-06-07
118
https://www.congress.gov/bill/118th-congress/senate-bill/1844
- sshr00
Health, Education, Labor, and Pensions Committee
Senate
Standing
  - Reported By
2023-07-26T21:19:40Z
  - Markup By
2023-06-15T15:52:22Z
  - Referred To
2023-06-07T16:29:22Z

- Animal Drug and Animal Generic Drug User Fee Amendments of 2023
118
1418
HR
2023-09-20
Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.
  - Related bill
CRS

- Innovative FEED Act
118
1842
S
2023-06-07
Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
  - Related bill
CRS

- Continuing Appropriations Act, 2024 and Other Extensions Act
118
5860
HR
2023-09-30
Became Public Law No: 118-15.
  - Related bill
CRS

- Innovative FEED Act of 2023
118
6687
HR
2023-12-08
Referred to the Subcommittee on Health.
  - Related bill
CRS
- 2023-07-26
Senate
Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
Calendars
- 2023-07-26
  - sshr00
Health, Education, Labor, and Pensions Committee
Senate
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment. Without written report.
Committee
- 2023-07-26
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment. Without written report.
Committee
14000
9
Library of Congress
  - sshr00
Health, Education, Labor, and Pensions Committee
- 2023-06-15
  - sshr00
Health, Education, Labor, and Pensions Committee
Senate
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment favorably.
Committee
- 2023-06-07
  - sshr00
Health, Education, Labor, and Pensions Committee
Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
IntroReferral
- 2023-06-07
Introduced in Senate
IntroReferral
10000
9
Library of Congress
- B001230
Sen. Baldwin, Tammy [D-WI]
Tammy
Baldwin
D
WI
N
- M001190
Sen. Mullin, Markwayne [R-OK]
Markwayne
Mullin
R
OK
2023-06-07
True
Health
- Research and development
2023-06-16T19:30:33Z
- User charges and fees
2023-06-16T19:30:33Z
- Veterinary medicine and animal diseases
2023-06-16T19:30:33Z
Health
2023-06-13T20:30:25Z
00
2023-06-07
Introduced in Senate
2023-09-27T15:19:34Z
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements.
The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of major species (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); and (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria).
Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.
25
2023-07-26
Reported to Senate
2024-11-07T19:30:29Z
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements.
The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of major species (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria); and (4) provides for the regulation of zootechnical animal food substances as food additives (zootechnical animal food substances are added to the food or drinking water of animals to affect the byproducts of the animal's digestion, reduce foodborne pathogens, or alter the animal's gastrointestinal biome).
Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.

Animal Drug and Animal Generic Drug User Fee Amendments of 2023
- Display Title
45

Animal Drug and Animal Generic Drug User Fee Amendments of 2023
2024-07-24T15:21:21Z
- Short Title(s) as Introduced
101

Animal Drug and Animal Generic Drug User Fee Amendments of 2023
2024-05-24T13:39:38Z
Introduced in Senate
IS
- Short Title(s) as Introduced for portions of this bill
106

Animal Generic Drug User Fee Amendments of 2023
2024-05-24T13:39:38Z
Introduced in Senate
IS
- Short Title(s) as Introduced for portions of this bill
106

Animal Drug User Fee Amendments of 2023
2024-05-24T13:39:38Z
Introduced in Senate
IS
- Short Title(s) as Reported to Senate for portions of this bill
108

Animal Generic Drug User Fee Amendments of 2023
2024-05-24T13:38:16Z
S
Senate
Reported to Senate
RS
- Short Title(s) as Reported to Senate for portions of this bill
108

Animal Drug User Fee Amendments of 2023
2024-05-24T13:38:16Z
S
Senate
Reported to Senate
RS
- Short Title(s) as Reported to Senate
103

Animal Drug and Animal Generic Drug User Fee Amendments of 2023
2024-05-24T13:38:16Z
S
Senate
Reported to Senate
RS
- Official Title as Introduced
6

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.
2023-06-10T03:14:03Z
Introduced in Senate
IS
- Reported to Senate
2023-07-26T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118s1844rs/xml/BILLS-118s1844rs.xml
- Introduced in Senate
2023-06-07T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118s1844is/xml/BILLS-118s1844is.xml
2023-07-26
Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.